Table 3.

Follow-up data and measurements after 6 and 12 months.

(i) Scores from EQ-6D and SF-12v2 questionnaires

(ii) HbA1c levels within the preceding 6 months, to be reported both by the user and the healthcare professional

(iii) Any diabetes-related hospitalizations

(iv) Changes in presence of complications

(v) Self-reported number of diabetes-related hospitalizations in the previous year

(vi) Self-reported estimated/felt/measured hypoglycemias in three months before filling out questionnaires; specific categorization for severe (grade III) hypoglycemia

(vii) Self-reported levels of working day losses or reduced functioning (including sports performance) due to dysregulation of DM

(viii) DVN questionnaire

(ix) Satisfaction from the use of FLS-FM